Previous close | 13,298.00 |
Open | 13,298.00 |
Bid | 13,222.50 x N/A |
Ask | 13,306.00 x N/A |
Day's range | 13,200.00 - 13,311.50 |
52-week range | 4,350.00 - 14,376.00 |
Volume | |
Avg. volume | 154 |
Market cap | 107.661T |
Beta (5Y monthly) | 0.27 |
PE ratio (TTM) | 21.19 |
EPS (TTM) | 622.90 |
Earnings date | 31 Jul 2024 |
Forward dividend & yield | 333.39 (2.40%) |
Ex-dividend date | 16 May 2024 |
1y target est | N/A |
PHILADELPHIA, June 07, 2024--US FDA approves expanded age indication for GSK’s AREXVY, the first respiratory syncytial virus (RSV) vaccine for adults aged 50-59 at increased risk
We recently compiled a list of 20 Cities With the Highest HIV/AIDS Rates in the US and in this article, we will talk about the city with the highest HIV/AIDS rates in the US. HIV Incidence and Prevalence in the United States The government of the United States has set a goal to reduce the […]
The simplest way to invest in stocks is to buy exchange traded funds. But one can do better than that by picking better...